| # | Drug | Count |
|---|---|---|
| 0 | INTERFERON BETA-1A | 28 |
| 1 | OCRELIZUMAB | 11 |
| 2 | BACLOFEN | 10 |
| 3 | IBUPFROFEN | 10 |
| 4 | IBUPROFEN | 10 |
| 5 | IBUPROFEN 200 MG | 10 |
| 6 | IBUPROFEN 200MG | 10 |
| 7 | IBUPROFEN CAPSULE | 10 |
| 8 | IBUPROFEN CAPSULES 200 MG | 10 |
| 9 | IBUPROFEN ORAL | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BUTENAFINE HYDROCHLORIDE | 1 | 0.0017 |
| 1 | MINERAL OIL, PETROLATUM | 1 | 0.0015 |
| 2 | BISACODYL 5MG | 1 | 0.0011 |
| 3 | SODIUM FLUORIDE AND POTASSIUM NITRATE | 1 | 0.0010 |
| 4 | PIOGLITAZONE AND METFORMIN HYDROCHLORIDE | 1 | 0.0008 |
| 5 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 2 | 0.0007 |
| 6 | FERRIC CARBOXYMALTOSE | 3 | 0.0006 |
| 7 | PERMETHRIN | 1 | 0.0006 |
| 8 | BACILLUS CALMETTE-GUERIN | 1 | 0.0006 |
| 9 | DHEA (DEHYDROEPIANDROSTERONE) | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interferon beta [EPC] | 29 |
| 1 | Integrin Receptor Antagonist [EPC] | 20 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 16 |
| 3 | Benzodiazepine [EPC] | 13 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 12 |
| 5 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 10 |
| 6 | Estrogen [EPC] | 9 |
| 7 | Provitamin D2 Compound [EPC] | 9 |
| 8 | Anti-epileptic Agent [EPC] | 8 |
| 9 | beta-Adrenergic Blocker [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Pyrethroid [EPC] | 1 | 0.0006 |
| 1 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 1 | 0.0006 |
| 2 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 3 | Provitamin D2 Compound [EPC] | 9 | 0.0003 |
| 4 | Integrin Receptor Antagonist [EPC] | 20 | 0.0002 |
| 5 | Interferon beta [EPC] | 29 | 0.0002 |
| 6 | Pyrimidine Synthesis Inhibitor [EPC] | 6 | 0.0001 |
| 7 | Cholinergic Muscarinic Antagonist [EPC] | 5 | 0.0001 |
| 8 | Cannabinoid [EPC] | 1 | 0.0001 |
| 9 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 10 | 0.0001 |